EHR

AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities

CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...

AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities

CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors

Enrollment progressing toward interim analysis planned when 36 subjects reach 12 weeks on treatment in Part 1 of studyBOSTON and...

Spinogenix Receives Approval from the Australia Human Research Ethics Committee to Initiate a Phase 1 Human Clinical Trial of SPG302, a Novel Regenerative Drug for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Safe group group reports half-year revenues of €2.9m

                                                                                                                                                    Safe group group reports half-year revenues of €2.9m      Second-quarter revenue of €1.4M in Q2 2022, stable compared with Q1...

FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the...

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

CINCINNATI, Ohio, June 28, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a...

Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposium

ART26.12, a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor, Shows Favorable Results in Studies for Chemotherapy-Induced Neuropathy and Diabetic...

error: Content is protected !!